/

Other

/

Nemera

Nemera

Nemera

Verified Nov 2026

Other

·

France flag

Lyon, Rhone-Alpes

·

Since 2015

Nemera is a drug delivery device company headquartered in Lyon, France, founded in 2015. It has an estimated 1,000 to 5,000 employees and an estimated revenue band of $500 million to $1 billion, and it is privately held. The company designs and manufactures parenteral, inhalation, and nasal delivery devices for the pharmaceutical and biotechnology sectors, and its industry tags also list automotive, medical, and renewable energy. In September 2026 it inaugurated a production facility in Ponts-et-Marais, France.

Nemera

Verified Nov 2026

AT A GLANCE

Founded

2015

Headquarters

France flag

Lyon, Rhone-Alpes

Employees

1,000-5,000

Ownership

Nemera at a glance

Revenue

$500M-1B

Est. band

Employees

1,000-5,000

Founded

2015

Headquarters

Lyon, Rhone-Alpes

Certifications

ISO 14001 · ISO 45001

Import activity

70

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

70

Named foreign suppliers

23

Top origins

Germany · Netherlands · Costa Rica · France

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Nemera.

What this tells a buyer

Nemera's public record includes five dated developments from April to September 2026, most recently the launch of its DuoSpray intranasal delivery platform on 3 September 2026, though no customs trade data was found.

Nemera holds ISO 14001 and ISO 45001 certifications and lists capabilities in injection molding, assembly, pump, glass, welding, mold, and electronics work.

Nemera operates facilities in Ponts-et-Marais, France and Szczecin, Poland, and its revenue band is an estimate rather than a reported figure.

Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026

STABILITY SIGNALS

Established & active

11 years in operation (founded 2015).

Holds ISO 14001, ISO 45001 certification(s) per public sources.

Overview

Nemera is a drug delivery device company headquartered in Lyon, France, founded in 2015. It has an estimated 1,000 to 5,000 employees and an estimated revenue band of $500 million to $1 billion, and it is privately held. The company designs and manufactures parenteral, inhalation, and nasal delivery devices for the pharmaceutical and biotechnology sectors, and its industry tags also list automotive, medical, and renewable energy. In September 2026 it inaugurated a production facility in Ponts-et-Marais, France.

At a glance

Attribute

Detail

Founded

2015

Headquarters

Lyon, Rhone-Alpes

Employees

1,000-5,000

Revenue

$500M-1B (estimated)

Certifications

ISO 14001 · ISO 45001

What Nemera makes

Nemera holds ISO 14001 and ISO 45001 certifications and lists capabilities in injection molding, assembly, pump, glass, welding, mold, and electronics work.

Products and capabilities described on the company's own site include Injection Molding, Assembly, Pump, Glass, Welding, Mold, Electronics (source: nemera.net).

Certifications

Nemera is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Trade and customs footprint

Nemera's public record includes five dated developments from April to September 2026, most recently the launch of its DuoSpray intranasal delivery platform on 3 September 2026, though no customs trade data was found. US customs bill-of-lading records list 70 inbound shipments across 23 foreign suppliers, with top origins including Germany · Netherlands · Costa Rica · France.

Latest developments

Facilities

Nemera is headquartered in Lyon, Rhone-Alpes. Public sources also reference these locations:

Company details

Nemera operates facilities in Ponts-et-Marais, France and Szczecin, Poland, and its revenue band is an estimate rather than a reported figure. Nemera was founded in 2015, has an estimated 1,000-5,000 employees, and is headquartered in Lyon, Rhone-Alpes. On the LightSource stability read it is rated "Established & active": 11 years in operation (founded 2015). Holds ISO 14001, ISO 45001 certification(s) per public sources.

Frequently asked questions

What does Nemera do?

Nemera is a drug delivery device company headquartered in Lyon, France, founded in 2015. It has an estimated 1,000 to 5,000 employees and an estimated revenue band of $500 million to $1 billion, and it is privately held. The company designs and manufactures parenteral, inhalation, and nasal delivery devices for the pharmaceutical and biotechnology sectors, and its industry tags also list automotive, medical, and renewable energy. In September 2026 it inaugurated a production facility in Ponts-et-Marais, France.

Where is Nemera headquartered?

Nemera is headquartered in Lyon, Rhone-Alpes.

When was Nemera founded?

Nemera was founded in 2015.

How big is Nemera?

Nemera has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).

What certifications does Nemera hold?

Nemera lists ISO 14001 · ISO 45001 on its website. Confirm the certified scope for the specific plant producing your part.

Does Nemera import from overseas suppliers?

US customs bill-of-lading records show 70 inbound shipments for Nemera, with top origins including Germany · Netherlands · Costa Rica · France.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Lyon, Rhone-Alpes (HQ)Headquarters · Rhone-Alpes, France
Lyon, Rhone-Alpes (HQ)Lyon, Rhone-Alpes, FranceHeadquarters

Phone

+33 4 74 94 06 54

Certification

ISO 14001 · ISO 45001

Evaluating suppliers like these?

This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.